知镜 Cognispect · 医学文献与研究工作台

The Prevalence of Nutritional Disorders in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Chen T, Zhou Z, Guo M, Pan Y, Guo Z, Xie W, Xiao S.
Advances in nutrition (Bethesda, Md.) · 2026-10-17 · PMID 42892557

文献摘要

The epidemiology of nutritional disorders in inflammatory bowel disease (IBD) remains poorly characterized. Existing evidence is fragmented across specific conditions or confined to single regions, and no study has simultaneously assessed the principal nutritional disorders-malnutrition, overweight or obesity, and sarcopenia-in a unified framework. To address this gap, we systematically searched PubMed, Embase, Cochrane Library, and China Biology Medicine from inception to 31 July, 2024 and updated on 30 July, 2026. Observational studies reporting prevalence based on standard diagnostic criteria were included. Pooled estimates with 95% confidence interval (CI) and prediction interval (PI) were derived using a random-effects model. Prespecified subgroup analyses were conducted by sex, age, disease subtype and activity, diagnostic criteria, study setting, and geographic variation. Study quality and publication bias were also assessed. After literature screening, 201 studies across 32 countries were included. Underweight affected 11.5% (95% CI: 9.0%, 14.6%, 95% PI: 1.0%, 61.7%), whereas consensus-based malnutrition (Global Leadership Initiative on Malnutrition, European Society for Clinical Nutrition and Metabolism, Mini Nutritional Assessment, Subjective Global Assessment or its variant Patient-Generated -Subjective Global Assessment) affected 27.6% (95% CI: 20.5%, 36.1%, 95% PI: 3.6%, 79.7%). Notably, this malnutrition estimate was derived almost exclusively from hospital-based settings (>80%) and predominantly from a single region. Overweight and obesity affected 23.1% (95% CI: 20.6%, 25.9%, 95% PI: 8.1%, 50.8%) and 13.5% (95% CI: 11.7%, 15.6%, 95% PI: 2.9%, 44.6%), respectively. For muscle depletion, low muscle mass defined by skeletal muscle index was identified in 48.3% (95% CI: 41.8%, 55.0%, 95% PI: 19.7%, 78.1%), whereas consensus-based sarcopenia (European Working Group on Sarcopenia in Older People or Asian Working Group on Sarcopenia) affected 12.6% (95% CI: 6.1%, 24.2%, 95% PI: 0.9%, 70.6%). Of note, the majority of included studies for malnutrition and sarcopenia were hospital based. Active disease was associated with a significantly higher prevalence of malnutrition. No significant differences were observed between disease subtypes. In conclusion, our findings provide a broad overview of the prevalence of major nutritional disorders in patients with IBD, highlighting that nutritional care in IBD should extend beyond simple weight monitoring. However, given the wide PIs, these pooled estimates reflect the overall level across highly heterogeneous settings rather than a precise global figure. Future research, particularly population-based studies with standardized diagnostic criteria across diverse regions, is needed to validate our observation. The study protocol was registered a priori at PROSPERO as CRD42024592104.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。